Melan-A/MART-1(51–73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells

Gelijkaardige items

• gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells
  door: Kierstead, L S, et al.
  Gepubliceerd in: (2001)
• Identification of naturally processed and HLA-presented Epstein–Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood
  door: Herr, Wolfgang, et al.
  Gepubliceerd in: (1999)
• Identification of an HLA-DPB1*0501 Restricted Melan-A/MART-1 Epitope Recognized by CD4(+) T Lymphocytes: Prevalence for Immunotherapy in Asian Populations
  door: Meng, Zhaoting, et al.
  Gepubliceerd in: (2011)
• Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes
  door: Adamina, M, et al.
  Gepubliceerd in: (2004)
• Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1
  door: Waterman, E A, et al.
  Gepubliceerd in: (2002)